The G8 Dementia Research Summit-a starter for eight?

Nick C. Fox; Ronald C. Petersen

doi:10.1016/S0140-6736(13)62426-5

The G8 Dementia Research Summit-a starter for eight?

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1968-1969
Number of pages	2
Journal	The Lancet
Volume	382
Issue number	9909
DOIs	https://doi.org/10.1016/S0140-6736(13)62426-5
State	Published - 2013

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1016/S0140-6736(13)62426-5

Cite this

@article{65ad3c139b694a4fb12839a428d8db34,

title = "The G8 Dementia Research Summit-a starter for eight?",

author = "Fox, {Nick C.} and Petersen, {Ronald C.}",

note = "Funding Information: NCF's research group has received research support or payment for image analysis from Eisai, GE Healthcare, GlaxoSmithKline, IXICO, Janssen, Johnson & Johnson, Lilly, Novartis, Pfizer, and Sanofi. RCP has served on data monitoring committees for Pfizer and Janssen, as a consultant for Roche and GE Healthcare, and participated in an advisory meeting for Elan Pharmaceuticals in 2010. NCF acknowledges support from Alzheimer's Research UK, the Brain Research Trust, the Wolfson Foundation, and the NIHR Queen Square Dementia Biomedical Research Unit. RCP acknowledges NIH/NIA support. RCP chairs the Advisory Council for Research, Care and Services of the US National Alzheimer's Project Act. NCF cochairs the Alzheimer's Society Research Strategy Committee. We are grateful for helpful discussions with Eric Karran (ARUK) and Doug Brown (Alzheimer's Society).",

year = "2013",

doi = "10.1016/S0140-6736(13)62426-5",

language = "English (US)",

volume = "382",

pages = "1968--1969",

journal = "The Lancet",

issn = "0140-6736",